C. M. Tobin

624 total citations
11 papers, 416 citations indexed

About

C. M. Tobin is a scholar working on Pharmacology, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, C. M. Tobin has authored 11 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Infectious Diseases and 3 papers in Clinical Biochemistry. Recurrent topics in C. M. Tobin's work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Bacterial Identification and Susceptibility Testing (3 papers). C. M. Tobin is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (7 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Bacterial Identification and Susceptibility Testing (3 papers). C. M. Tobin collaborates with scholars based in United Kingdom and France. C. M. Tobin's co-authors include Andrew Lovering, Alasdair MacGowan, M.‐A. Gall, Alison H. Thomson, Christine E. Staatz, A. M. Lovering, Edward A. Sweeney, Tony Whitehouse, Rob Shulman and Mervyn Singer and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, International Journal of Antimicrobial Agents and Journal of Infection.

In The Last Decade

C. M. Tobin

11 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. M. Tobin United Kingdom 7 292 276 138 85 41 11 416
Pejman Dehghanyar Austria 11 326 1.1× 146 0.5× 99 0.7× 119 1.4× 34 0.8× 11 525
Akiko Mizoguchi Japan 10 234 0.8× 245 0.9× 108 0.8× 55 0.6× 11 0.3× 18 339
Stefanie Swoboda Germany 15 284 1.0× 255 0.9× 73 0.5× 168 2.0× 40 1.0× 32 644
Akari Shigemi Japan 15 392 1.3× 392 1.4× 152 1.1× 210 2.5× 16 0.4× 31 652
A. M. Lovering United Kingdom 13 216 0.7× 249 0.9× 98 0.7× 168 2.0× 15 0.4× 26 611
Marie-France Kerguéris France 8 135 0.5× 121 0.4× 74 0.5× 99 1.2× 9 0.2× 12 329
Randy D. Pryka United States 11 257 0.9× 174 0.6× 58 0.4× 107 1.3× 22 0.5× 14 347
Jicheng Yu China 15 336 1.2× 143 0.5× 53 0.4× 189 2.2× 67 1.6× 54 543
Amira A. Bhalodi United States 9 161 0.6× 152 0.6× 101 0.7× 88 1.0× 12 0.3× 18 381
Yoshihiro Shimodozono Japan 9 161 0.6× 246 0.9× 72 0.5× 117 1.4× 5 0.1× 14 345

Countries citing papers authored by C. M. Tobin

Since Specialization
Citations

This map shows the geographic impact of C. M. Tobin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. M. Tobin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. M. Tobin more than expected).

Fields of papers citing papers by C. M. Tobin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. M. Tobin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. M. Tobin. The network helps show where C. M. Tobin may publish in the future.

Co-authorship network of co-authors of C. M. Tobin

This figure shows the co-authorship network connecting the top 25 collaborators of C. M. Tobin. A scholar is included among the top collaborators of C. M. Tobin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. M. Tobin. C. M. Tobin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Tobin, C. M., A. M. Lovering, Edward A. Sweeney, & Alasdair MacGowan. (2010). Analyses of teicoplanin concentrations from 1994 to 2006 from a UK assay service. Journal of Antimicrobial Chemotherapy. 65(10). 2155–2157. 43 indexed citations
2.
Thomson, Alison H., Christine E. Staatz, C. M. Tobin, M.‐A. Gall, & Andrew Lovering. (2009). Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations. Journal of Antimicrobial Chemotherapy. 63(5). 1050–1057. 120 indexed citations
3.
Wen, Tao, et al.. (2007). Maturation of the 5' end of Bacillus subtilis 16S rRNA by the essential ribonuclease YkqC/RNase J1. HAL (Le Centre pour la Communication Scientifique Directe). 2 indexed citations
4.
Soltani, Mehnam, et al.. (2006). Evidence of excessive concentrations of 5-flucytosine in children aged below 12 years: a 12-year review of serum concentrations from a UK clinical assay reference laboratory. International Journal of Antimicrobial Agents. 28(6). 574–577. 28 indexed citations
5.
Whitehouse, Tony, Jorge Cepeda, Rob Shulman, et al.. (2005). Pharmacokinetic studies of linezolid and teicoplanin in the critically ill. Journal of Antimicrobial Chemotherapy. 55(3). 333–340. 65 indexed citations
6.
Lovering, Andrew, et al.. (2004). A reverse-phase HPLC assay for the simultaneous determination of enrofloxacin and ciprofloxacin in pig faeces. International Journal of Antimicrobial Agents. 23(4). 390–393. 23 indexed citations
7.
Lovering, Andrew, et al.. (2004). Determination of avilamycin A and B in pig faeces by solid phase extraction and reverse-phase HPLC assay. International Journal of Antimicrobial Agents. 24(5). 511–514. 4 indexed citations
8.
Whitehouse, Tony, et al.. (2002). The Pharmacokinetic Profiles of Linezolid and Teicoplanin in the critically ill. UCL Discovery (University College London). 1 indexed citations
9.
10.
Rana, B, et al.. (2002). Penetration of linezolid into osteoarticular tissues. Journal of Infection. 44(2). 112–112. 3 indexed citations
11.
Tobin, C. M.. (2001). A simple, isocratic high-performance liquid chromatography assay for linezolid in human serum. Journal of Antimicrobial Chemotherapy. 48(5). 605–608. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pejman Dehghanyar Breakdown of academic impact, for papers by Akiko Mizoguchi Breakdown of academic impact, for papers by Stefanie Swoboda Breakdown of academic impact, for papers by Akari Shigemi Breakdown of academic impact, for papers by A. M. Lovering Breakdown of academic impact, for papers by Marie-France Kerguéris Breakdown of academic impact, for papers by Randy D. Pryka Breakdown of academic impact, for papers by Jicheng Yu Breakdown of academic impact, for papers by Amira A. Bhalodi Breakdown of academic impact, for papers by Yoshihiro Shimodozono
Rankless by CCL
2026